Medication info
Mupain Semi Sustained-Release Tablet

Mupain Semi Sustained-Release Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Pale yellow, round, sustained-release film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201506782 · Approved 2015.09.24 · Insurance code 669906380

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. A dose of 2 tablets is recommended initially. Thereafter, allow an interval of at least 12 hours between doses and do not exceed 8 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; therefore, monitor the patient's response closely and adjust treatment as appropriate. Elderly patients: Use the usual adult dose. However, because oral administration of tramadol to elderly patients aged 75 years or older increased the elimination half-life of tramadol by 17%, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • moderate to severe chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. A dose of 2 tablets is recommended initially. Thereafter, allow an interval of at least 12 hours between doses and do not exceed 8 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; therefore, monitor the patient's response closely and adjust treatment as appropriate. Elderly patients: Use the usual adult dose. However, because oral administration of tramadol to elderly patients aged 75 years or older increased the elimination half-life of tramadol by 17%, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Precautions

This medication may cause liver damage if taken by individuals who regularly consume more than three alcoholic drinks daily, so consultation with a doctor or pharmacist is essential. This medication can rarely cause serious skin reactions; if a skin rash or allergy symptoms occur, discontinue use immediately and consult a healthcare professional. Due to the presence of tramadol, exceeding the recommended dose may increase the risk of seizures, and the risk of seizures is also heightened when taken with certain antidepressants or other central nervous system medications. In patients with severe respiratory diseases, this medication may inhibit respiration; therefore, it should only be administered in an environment where medical equipment is prepared. Taking this medication with alcohol or benzodiazepines may result in severe sedation, respiratory suppression, or coma, requiring caution. Patients with elevated intracranial pressure or head injuries should use this medication cautiously as it may worsen brain pressure through respiratory suppression. As tramadol is an opioid medication, it may induce physical and psychological dependence, making careful monitoring necessary for long-term use. Patients with impaired liver function may experience liver damage due to the acetaminophen contained in this medication, so it must only be taken after consulting a physician. Particularly, patients who are ultra-rapid metabolizers for CYP2D6 should be monitored for dosage adjustments due to increased risk of respiratory suppression resulting from rapid drug metabolism. This medication should not be administered to children under the age of 12 or to individuals under 18 years who have undergone tonsillectomy or adenoidectomy; adolescents aged 12 to 18 should also avoid use if they have risk factors. Elderly patients or those at risk for hyponatremia should regularly check their blood sodium levels due to the possibility of developing hyponatremia. Patients with hypersensitivity to any components of this medication, central nervous system drug intoxication, severe respiratory depression, head injuries, etc., should not be administered this medication. Pregnant and breastfeeding individuals must consult a doctor before using this medication, as it may affect the fetus or newborn; especially during breastfeeding, the medication can be transmitted through breast milk, posing risks to the baby. Caution is needed when driving or operating machinery, as dizziness or drowsiness may occur due to this medication. In the case of overdose, severe respiratory depression, liver damage, etc., may occur, requiring immediate medical attention; treatment may involve respiratory support and antidotes. During treatment with this medication, avoid taking other tramadol or acetaminophen products concurrently. This medication is an opioid drug, which has the potential for dependence or abuse, and withdrawal symptoms may occur, so abrupt discontinuation should be avoided. When used in conjunction with other central nervous system depressants, reduce the dosage and closely monitor the patient's condition. Patients with impaired liver, kidney, or heart function and elderly patients need to exercise increased caution when taking this medication.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, rigidity, fainting, withdrawal symptoms, hypertension, exacerbation of hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremors, ataxia, convulsions, hypertonia, migraine, exacerbation of migraine, involuntary muscle contractions, sensory disturbances, delirium, vertigo, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stools, tongue swelling, loss of appetite, anxiety, confusion, euphoria, insomnia, nervousness, drowsiness, forgetfulness, depersonalization, depression, drug abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thoughts, anemia, dyspnea, proteinuria, urinary disturbances, oliguria, urinary retention, pruritus, rash, sweating, urticaria, abnormal liver function, weight loss, tinnitus, abnormal vision, chills, vasodilation, orthostatic hypotension, bradycardia, exhaustion, myocardial ischemia, pulmonary edema, bronchospasm, wheezing, angioedema, allergic reactions, anaphylaxis, Stevens-Johnson syndrome, changes in appetite, exercise weakness, respiratory depression, cognitive dysfunction, difficulty concentrating, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, delirium, miosis, mydriasis, speech disorders, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hypoprothrombinemia, high anion gap metabolic acidosis, weakness, fever, edema, rigidity, fainting, congestive heart failure, dizziness, delirium, exercise-induced dyspnea, cough, bronchitis, hematuria, dark urine, anuria, urinary incontinence, upper abdominal pain, peptic ulcer, belching, peripheral edema, pallor, blood pressure fluctuations, cough, rhinorrhea, blood pressure increase, palpitations, irregular menstruation, gastrointestinal bleeding, cholesterol increase, hip pain, thigh pain, allergic rhinitis, epistaxis, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, paralytic ileus, cholecystitis, hiccups, increased saliva, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, drowsiness, insomnia, nervousness, hallucinations, depersonalization, decrease in hemoglobin, decrease in red blood cells, decrease in white blood cells, increase in white blood cells, decrease in platelets, palpitations, aortic stenosis, delirium, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, confusion, multiple organ failure, intentional overdose, heartburn, acute gastritis, cold, upper respiratory tract infection, systemic weakness, motion sickness, lethargy, memory impairment, insufficient effect, facial flushing

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container, protected from air and moisture. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius, avoiding extremely hot or cold places.

Appearance and packaging

Appearance

Pale yellow, round, sustained-release film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.